XML 54 R41.htm IDEA: XBRL DOCUMENT v3.22.0.1
Selected Quarterly Financial Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2021
Quarterly Financial Information Disclosure [Abstract]  
Unaudited Quarterly Data The tables below set forth the Company’s quarterly Consolidated Statements of Operations data for the eight quarters ended December 31, 2021.

 

Three Months Ended

 

 

Dec. 31,

2021

 

 

Sept. 30,

2021

 

 

June 30,

2021

 

 

Mar. 31,

2021

 

 

Dec. 31,

2020

 

 

Sept. 30,

2020

 

 

June 30,

2020

 

 

Mar. 31,

2020

 

 

(dollars in thousands, except per share data)

 

Statement of Operations Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

251,671

 

 

$

227,868

 

 

$

153,616

 

 

$

359,429

 

 

$

294,978

 

 

$

101,716

 

 

$

17,265

 

 

$

7,753

 

Cost of revenue

 

62,134

 

 

 

43,466

 

 

 

35,858

 

 

 

74,075

 

 

 

51,772

 

 

 

26,261

 

 

 

7,717

 

 

 

4,057

 

Gross profit

 

189,537

 

 

 

184,402

 

 

 

117,758

 

 

 

285,354

 

 

 

243,206

 

 

 

75,455

 

 

 

9,548

 

 

 

3,696

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

7,464

 

 

 

6,021

 

 

 

5,312

 

 

 

5,422

 

 

 

4,576

 

 

 

3,177

 

 

 

1,849

 

 

 

1,978

 

Selling and marketing

 

8,200

 

 

 

6,012

 

 

 

5,219

 

 

 

5,008

 

 

 

5,081

 

 

 

5,014

 

 

 

3,260

 

 

 

1,597

 

General and administrative

 

22,102

 

 

 

12,299

 

 

 

8,329

 

 

 

8,002

 

 

 

7,640

 

 

 

3,741

 

 

 

1,799

 

 

 

2,035

 

Amortization of intangible assets

 

911

 

 

 

797

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

38,677

 

 

 

25,129

 

 

 

18,860

 

 

 

18,432

 

 

 

17,297

 

 

 

11,932

 

 

 

6,908

 

 

 

5,610

 

Operating income (loss)

 

150,860

 

 

 

159,273

 

 

 

98,898

 

 

 

266,922

 

 

 

225,909

 

 

 

63,523

 

 

 

2,640

 

 

 

(1,914

)

Interest and other (expense) income, net

 

(35

)

 

 

496

 

 

 

604

 

 

 

282

 

 

 

589

 

 

 

421

 

 

 

275

 

 

 

241

 

Income (loss) before income taxes, equity earnings (loss) in investee and gain (loss) on equity-method investments

 

150,825

 

 

 

159,769

 

 

 

99,502

 

 

 

267,204

 

 

 

226,498

 

 

 

63,944

 

 

 

2,915

 

 

 

(1,673

)

Provision for (benefit from) income taxes

 

47,148

 

 

 

37,545

 

 

 

23,589

 

 

 

66,513

 

 

 

58,571

 

 

 

14,526

 

 

 

(599

)

 

 

34

 

Income (loss) before equity earnings (loss) in investee and gain (loss) on equity-method investments

 

103,677

 

 

 

122,224

 

 

 

75,913

 

 

 

200,691

 

 

 

167,927

 

 

 

49,418

 

 

 

3,514

 

 

 

(1,707

)

Equity earnings (loss) in investee

 

 

 

 

 

 

 

 

 

 

 

 

 

143

 

 

 

(189

)

 

 

(193

)

 

 

(249

)

Gain (loss) on equity-method investments

 

 

 

 

 

 

 

3,734

 

 

 

 

 

 

(1,763

)

 

 

(2,591

)

 

 

 

 

 

 

Net income (loss) from consolidated operations

 

103,677

 

 

 

122,224

 

 

 

79,647

 

 

 

200,691

 

 

 

166,307

 

 

 

46,638

 

 

 

3,321

 

 

 

(1,956

)

Net loss attributable to noncontrolling interests

 

662

 

 

 

298

 

 

 

165

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Fulgent

$

104,339

 

 

$

122,522

 

 

$

79,812

 

 

$

200,691

 

 

$

166,307

 

 

$

46,638

 

 

$

3,321

 

 

$

(1,956

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per common share attributable to Fulgent:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

$

3.48

 

 

$

4.13

 

 

$

2.74

 

 

$

6.96

 

 

$

6.55

 

 

$

2.11

 

 

$

0.15

 

 

$

(0.09

)

Diluted

$

3.34

 

 

$

3.93

 

 

$

2.59

 

 

$

6.52

 

 

$

6.16

 

 

$

1.98

 

 

$

0.14

 

 

$

(0.09

)